ANTIDEPRESSANTS: TCAs, MAOIs
|
DRUG NAME
| Tertiary TCAs: amitriptyline (Elavil), imipramine, clomipramine (Anafranil) Secondary TCAs: desipramine (Norpramin), nortriptyline (Pamelor) | isocarboxazid (Marplan) phenelzine (Nardil) tranylcypromine (Parnate) selegiline (Emsam, Zelapar)
|
CLASS
| Tricyclic antidepressants (TCAs)
| Monoamine oxidase inhibitors (MAOIs)
|
MECHANISM OF ACTION
| Inhibition of serotonin and norepinephrine reuptake into nerve endings
| Monoamine oxidase inhibition to prevent the breakdown of serotonin, norepinephrine, and dopamine
|
INDICATIONS
| - Major depressive disorder
- Phobic, panic, anxiety disorders
- Obsessive-compulsive disorder
- Neuropathic pain
- Migraine prevention
| - Major depressive disorder
- Parkinson disease
|
ROUTE(S) OF ADMINISTRATION
| | - PO
- Transdermal (selegiline)
|
SIDE EFFECTS
| - Sedation
- Orthostatic hypotension
- Atropine-like side effects
- Lower seizure threshold
- Serotonin syndrome
- Black box warning: suicidal thinking in children, adolescents, and young adults
| - Hypertensive crisis
- Serotonin syndrome
- Black box warning: suicidal thinking in children, adolescents, and young adults
|
CONTRAINDICATIONS AND CAUTIONS
| - Administration within 14 days of MAOIs
| - Pheochromocytoma
- Cerebrovascular diseases
- Severe hepatic / renal impairment
- Dietary: avoid
- tyramine-rich food or drinks
- foods containing phenylalanine
- caffeine
|